Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Claude Sirlin

    TitleProfessor In Residence
    SchoolUniversity of California, San Diego
    DepartmentRadiology
    Address9500 Gilman Drive #0888
    CA La Jolla 92093
    Phone858-246-2203
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Havard UniversityB.A.Biology
      University of California, San FranciscoM.D.Medicine
      Collapse Awards and Honors
      Radiological Society of North America1996Research Resident Award
      Radiological Society of North America Research Roentgen 1998  - 1999Research Awards
      Elliot C. Lasser2000Award for Excellence in Research
      Stanford University2001 Radiology Teaching Award
      Society of Gastrointestinal Radiologists 2006Phillip H. Meyers Research Award
      Association of University Radiologists2007Radiology Research Alliance New Investigator Award
      ISMRM2008Outstanding Teacher Award: Case-Based Teaching Series
      UCSF2009Earl Miller Memorial Lecturer
      ESGAR2011SGR Honorary Lecturer

      Collapse Research 
      Collapse Research Activities and Funding
      QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
      NIH/NIDDK R01DK106419Jul 1, 2015 - May 31, 2020
      Role: Principal Investigator
      Development of MR-based biomarker panels for NAFLD - A NASH CRN Ancillary Study
      NIH/NIDDK R56DK090350Sep 30, 2010 - Aug 31, 2013
      Role: Principal Investigator
      Technical Validation of MRI Biomarkers of Liver Fat
      NIH/NIDDK R01DK088925Sep 15, 2010 - Jul 31, 2022
      Role: Principal Investigator
      MR Imaging of Non-Alcoholic Fatty Liver Disease
      NIH/NIDDK R01DK075128Sep 1, 2006 - Mar 31, 2012
      Role: Principal Investigator
      Training Clinical Scientists in Radiological Imaging
      NIH/NIBIB T32EB005970Apr 1, 2006 - Jun 30, 2018
      Role: Principal Investigator
      Transducible Molecular Probes for Imaging Tumors
      NIH/NCI K08CA102158Jul 18, 2003 - Jun 30, 2008
      Role: Principal Investigator

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, Hu HH, Hetterich H, Kühn JP, Kukuk GM, Loomba R, Middleton MS, Obuchowski NA, Song JS, Tang A, Wu X, Reeder SB, Sirlin C. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology. 2017 Sep 11; 170550. PMID: 28892458.
        View in: PubMed
      2. Hong CW, Mamidipalli A, Hooker JC, Hamilton G, Wolfson T, Chen DH, Fazeli Dehkordy S, Middleton MS, Reeder SB, Loomba R, Sirlin C. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis. J Magn Reson Imaging. 2017 Aug 29. PMID: 28851124.
        View in: PubMed
      3. Hong CW, Wolfson T, Sy EZ, Schlein AN, Hooker JC, Fazeli Dehkordy S, Hamilton G, Reeder SB, Loomba R, Sirlin C. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification. J Magn Reson Imaging. 2017 Aug 26. PMID: 28842937.
        View in: PubMed
      4. Caussy C, Soni M, Cui J, Bettencourt R, Schork N, Chen CH, Ikhwan MA, Bassirian S, Cepin S, Gonzalez MP, Mendler M, Kono Y, Vodkin I, Mekeel K, Haldorson J, Hemming A, Andrews B, Salotti J, Richards L, Brenner DA, Sirlin C, Loomba R. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. J Clin Invest. 2017 Jun 30; 127(7):2697-2704. PMID: 28628033.
        View in: PubMed
      5. Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, Brunt EM, Kleiner DE, Doo E, Van Natta ML, Lavine JE, Neuschwander-Tetri BA, Sanyal A, Loomba R, Sirlin C. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. Gastroenterology. 2017 Sep; 153(3):753-761. PMID: 28624576.
        View in: PubMed
      6. Sirlin C. Use of the Liver Imaging Reporting and Data System in Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y). 2017 Jun; 13(6):363-365. PMID: 28690453.
        View in: PubMed
      7. Mamidipalli A, Hamilton G, Manning P, Hong CW, Park CC, Wolfson T, Hooker J, Heba E, Schlein A, Gamst A, Durelle J, Paiz M, Middleton MS, Schwimmer JB, Sirlin C. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis. J Magn Reson Imaging. 2017 May 25. PMID: 28543915.
        View in: PubMed
      8. Serai SD, Obuchowski NA, Venkatesh SK, Sirlin C, Miller FH, Ashton E, Cole PE, Ehman RL. Repeatability of MR Elastography of Liver: A Meta-Analysis. Radiology. 2017 Oct; 285(1):92-100. PMID: 28530847.
        View in: PubMed
      9. Schwimmer JB, Behling C, Angeles JE, Paiz M, Durelle J, Africa J, Newton KP, Brunt EM, Lavine JE, Abrams SH, Masand P, Krishnamurthy R, Wong K, Ehman RL, Yin M, Glaser KJ, Dzyubak B, Wolfson T, Gamst AC, Hooker J, Haufe W, Schlein A, Hamilton G, Middleton MS, Sirlin C. Magnetic Resonance Elastography Measured Shear Stiffness as a Biomarker of Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. Hepatology. 2017 May 11. PMID: 28493388.
        View in: PubMed
      10. Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin C, Schnabl B, Brinkac L, Schork N, Chen CH, Brenner DA, Biggs W, Yooseph S, Venter JC, Nelson KE. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017 May 02; 25(5):1054-1062.e5. PMID: 28467925.
        View in: PubMed
      11. Haufe WM, Wolfson T, Hooker CA, Hooker JC, Covarrubias Y, Schlein AN, Hamilton G, Middleton MS, Angeles JE, Hernando D, Reeder SB, Schwimmer JB, Sirlin C. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference. J Magn Reson Imaging. 2017 Mar 21. PMID: 28323377.
        View in: PubMed
      12. Middleton MS, Haufe W, Hooker J, Borga M, Dahlqvist Leinhard O, Romu T, Tunón P, Hamilton G, Wolfson T, Gamst A, Loomba R, Sirlin C. Quantifying Abdominal Adipose Tissue and Thigh Muscle Volume and Hepatic Proton Density Fat Fraction: Repeatability and Accuracy of an MR Imaging-based, Semiautomated Analysis Method. Radiology. 2017 May; 283(2):438-449. PMID: 28278002.
        View in: PubMed
      13. Paige JS, Bernstein GS, Heba E, Costa EAC, Fereirra M, Wolfson T, Gamst AC, Valasek MA, Lin GY, Han A, Erdman JW, O'Brien WD, Andre MP, Loomba R, Sirlin C. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. AJR Am J Roentgenol. 2017 May; 208(5):W168-W177. PMID: 28267360.
        View in: PubMed
      14. Manning P, Murphy P, Wang K, Hooker J, Wolfson T, Middleton MS, Newton KP, Behling C, Awai HI, Durelle J, Paiz MN, Angeles JE, De La Pena D, McCutchan JA, Schwimmer JB, Sirlin C. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study. J Magn Reson Imaging. 2017 Oct; 46(4):1149-1158. PMID: 28225568.
        View in: PubMed
      15. Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, Hooker J, Sy E, Savides MT, Alquiraish MH, Valasek MA, Rizo E, Richards L, Brenner D, Sirlin C, Loomba R. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017 Feb; 152(3):598-607.e2. PMID: 27911262.
        View in: PubMed
      16. Patel NS, Hooker J, Gonzalez M, Bhatt A, Nguyen P, Ramirez K, Richards L, Rizo E, Hernandez C, Kisseleva T, Schnabl B, Brenner D, Sirlin C, Loomba R. Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2017 Mar; 15(3):463-464. PMID: 27712981.
        View in: PubMed
      17. Hamilton G, Schlein AN, Middleton MS, Hooker CA, Wolfson T, Gamst AC, Loomba R, Sirlin C. In vivo triglyceride composition of abdominal adipose tissue measured by 1 H MRS at 3T. J Magn Reson Imaging. 2017 May; 45(5):1455-1463. PMID: 27571403.
        View in: PubMed
      18. Mariappan YK, Dzyubak B, Glaser KJ, Venkatesh SK, Sirlin C, Hooker J, McGee KP, Ehman RL. Application of Modified Spin-Echo-based Sequences for Hepatic MR Elastography: Evaluation, Comparison with the Conventional Gradient-Echo Sequence, and Preliminary Clinical Experience. Radiology. 2017 Feb; 282(2):390-398. PMID: 27509543.
        View in: PubMed
      19. Cui J, Chen CH, Lo MT, Schork N, Bettencourt R, Gonzalez MP, Bhatt A, Hooker J, Shaffer K, Nelson KE, Long MT, Brenner DA, Sirlin C, Loomba R. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology. 2016 Nov; 64(5):1547-1558. PMID: 27315352.
        View in: PubMed
      20. Patel J, Bettencourt R, Cui J, Salotti J, Hooker J, Bhatt A, Hernandez C, Nguyen P, Aryafar H, Valasek M, Haufe W, Hooker C, Richards L, Sirlin C, Loomba R. Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therap Adv Gastroenterol. 2016 Sep; 9(5):692-701. PMID: 27582882; PMCID: PMC4984335.
      21. Dulai PS, Sirlin C, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol. 2016 Nov; 65(5):1006-1016. PMID: 27312947.
        View in: PubMed
      22. Cui J, Philo L, Nguyen P, Hofflich H, Hernandez C, Bettencourt R, Richards L, Salotti J, Bhatt A, Hooker J, Haufe W, Hooker C, Brenner DA, Sirlin C, Loomba R. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. J Hepatol. 2016 Aug; 65(2):369-76. PMID: 27151177.
        View in: PubMed
      23. Hernando D, Sharma SD, Aliyari Ghasabeh M, Alvis BD, Arora SS, Hamilton G, Pan L, Shaffer JM, Sofue K, Szeverenyi NM, Welch EB, Yuan Q, Bashir MR, Kamel IR, Rice MJ, Sirlin C, Yokoo T, Reeder SB. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. Magn Reson Med. 2017 Apr; 77(4):1516-1524. PMID: 27080068.
        View in: PubMed
      24. Loomba R, Cui J, Wolfson T, Haufe W, Hooker J, Szeverenyi N, Ang B, Bhatt A, Wang K, Aryafar H, Behling C, Valasek MA, Lin GY, Gamst A, Brenner DA, Yin M, Glaser KJ, Ehman RL, Sirlin C. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. Am J Gastroenterol. 2016 Jul; 111(7):986-94. PMID: 27002798; PMCID: PMC5001170 [Available on 01/01/17].
      25. Lin SC, Ang B, Hernandez C, Bettencourt R, Jain R, Salotti J, Richards L, Kono Y, Bhatt A, Aryafar H, Lin GY, Valasek MA, Sirlin C, Brouha S, Loomba R. Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. Therap Adv Gastroenterol. 2016 Mar; 9(2):152-61. PMID: 26929777; PMCID: PMC4749859.
      26. Jacobs K, Brouha S, Bettencourt R, Barrett-Connor E, Sirlin C, Loomba R. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly. Clin Gastroenterol Hepatol. 2016 Sep; 14(9):1337-1344.e3. PMID: 26820400.
        View in: PubMed
      27. Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin C, Brenner DA, Behling CA, Vera DR. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nucl Med Biol. 2016 Feb; 43(2):179-87. PMID: 26872443.
        View in: PubMed
      28. Tyagi A, Yeganeh O, Levin Y, Hooker JC, Hamilton GC, Wolfson T, Gamst A, Zand AK, Heba E, Loomba R, Schwimmer J, Middleton MS, Sirlin C. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging. 2015 Oct; 40(8):3070-7. PMID: 26350282; PMCID: PMC4819976.
      29. Achmad E, Yokoo T, Hamilton G, Heba ER, Hooker JC, Changchien C, Schroeder M, Wolfson T, Gamst A, Schwimmer JB, Lavine JE, Sirlin C, Middleton MS. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease. Abdom Imaging. 2015 Oct; 40(8):3084-90. PMID: 26205992; PMCID: PMC4630122 [Available on 10/01/16].
      30. Tang A, Valasek MA, Sirlin C. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know. Adv Anat Pathol. 2015 Sep; 22(5):314-22. PMID: 26262514.
        View in: PubMed
      31. Yokoo T, Wolfson T, Iwaisako K, Peterson MR, Mani H, Goodman Z, Changchien C, Middleton MS, Gamst AC, Mazhar SM, Kono Y, Ho SB, Sirlin C. Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T. Biomed Res Int. 2015; 2015:387653. PMID: 26421287; PMCID: PMC4569760.
      32. Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, Nguyen P, Hernandez C, Richards L, Salotti J, Lin S, Seki E, Nelson KE, Sirlin C, Brenner D. Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study. Gastroenterology. 2015 Dec; 149(7):1784-93. PMID: 26299412; PMCID: PMC4663110 [Available on 12/01/16].
      33. Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, Gamst A, Loomba R, Sirlin C, Middleton MS. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging. 2016 Feb; 43(2):398-406. PMID: 26201284; PMCID: PMC4819980.
      34. Hamilton G, Middleton MS, Hooker JC, Haufe WM, Forbang NI, Allison MA, Loomba R, Sirlin C. In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence. J Magn Reson Imaging. 2015 Dec; 42(6):1538-43. PMID: 26114603; PMCID: PMC4691228 [Available on 12/01/16].
      35. Merkle EM, Zech CJ, Bartolozzi C, Bashir MR, Ba-Ssalamah A, Huppertz A, Lee JM, Ricke J, Sakamoto M, Sirlin C, Ye SL, Zeng M. Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol. 2016 Mar; 26(3):674-82. PMID: 26070500; PMCID: PMC4747985.
      36. Sirlin C. Imaging Techniques for Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y). 2015 Jun; 11(6):403-5. PMID: 27118935; PMCID: PMC4843035.
      37. Shah A, Tang A, Santillan C, Sirlin C. Cirrhotic liver: What's that nodule? The LI-RADS approach. J Magn Reson Imaging. 2016 Feb; 43(2):281-94. PMID: 25996905.
        View in: PubMed
      38. Costa EA, Cunha GM, Smorodinsky E, Cruite I, Tang A, Marks RM, Clark L, Wolfson T, Gamst A, Sicklick JK, Hemming A, Peterson MR, Middleton MS, Sirlin C. Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard. Radiology. 2015 Sep; 276(3):775-86. PMID: 25875972; PMCID: PMC4962530.
      39. Zand KA, Shah A, Heba E, Wolfson T, Hamilton G, Lam J, Chen J, Hooker JC, Gamst AC, Middleton MS, Schwimmer JB, Sirlin C. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. J Magn Reson Imaging. 2015 Nov; 42(5):1223-32. PMID: 25847512; PMCID: PMC4592685 [Available on 11/01/16].
      40. Hope TA, Fowler KJ, Sirlin C, Costa EA, Yee J, Yeh BM, Heiken JP. Hepatobiliary agents and their role in LI-RADS. Abdom Imaging. 2015 Mar; 40(3):613-25. PMID: 25287679.
        View in: PubMed
      41. Marks RM, Ryan A, Heba ER, Tang A, Wolfson TJ, Gamst AC, Sirlin C, Bashir MR. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol. 2015 Mar; 204(3):527-35. PMID: 25714281.
        View in: PubMed
      42. Loomba R, Sirlin C, Ang B, Bettencourt R, Jain R, Salotti J, Soaft L, Hooker J, Kono Y, Bhatt A, Hernandez L, Nguyen P, Noureddin M, Haufe W, Hooker C, Yin M, Ehman R, Lin GY, Valasek MA, Brenner DA, Richards L. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology. 2015 Apr; 61(4):1239-50. PMID: 25482832; PMCID: PMC4407930.
      43. Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, Lam J, Hooker JC, Hamilton G, Fontanesi J, Sirlin C. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology. 2015 Jun; 61(6):1887-95. PMID: 25529941; PMCID: PMC4670559.
      44. Arulanandan A, Ang B, Bettencourt R, Hooker J, Behling C, Lin GY, Valasek MA, Ix JH, Schnabl B, Sirlin C, Loomba R. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2015 Aug; 13(8):1513-20.e1. PMID: 25661453.
        View in: PubMed
      45. Artz NS, Haufe WM, Hooker CA, Hamilton G, Wolfson T, Campos GM, Gamst AC, Schwimmer JB, Sirlin C, Reeder SB. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects. J Magn Reson Imaging. 2015 Sep; 42(3):811-7. PMID: 25620624; PMCID: PMC4803480.
      46. Tang A, Chen J, Le TA, Changchien C, Hamilton G, Middleton MS, Loomba R, Sirlin C. Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis. Abdom Imaging. 2015 Jan; 40(1):26-37. PMID: 25015398; PMCID: PMC4293373.
      47. Lin SC, Heba E, Wolfson T, Ang B, Gamst A, Han A, Erdman JW, O'Brien WD, Andre MP, Sirlin C, Loomba R. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. Clin Gastroenterol Hepatol. 2015 Jul; 13(7):1337-1345.e6. PMID: 25478922; PMCID: PMC4454635.
      48. Loomba R, Wolfson T, Ang B, Hooker J, Behling C, Peterson M, Valasek M, Lin G, Brenner D, Gamst A, Ehman R, Sirlin C. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology. 2014 Dec; 60(6):1920-8. PMID: 25103310; PMCID: PMC4245360.
      49. Choi JY, Lee JM, Sirlin C. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014 Oct; 273(1):30-50. PMID: 25247563; PMCID: PMC4263770.
      50. Murphy P, Hooker J, Ang B, Wolfson T, Gamst A, Bydder M, Middleton M, Peterson M, Behling C, Loomba R, Sirlin C. Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. J Magn Reson Imaging. 2015 Jun; 41(6):1629-38. PMID: 25256692; PMCID: PMC4819971.
      51. Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin C. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology. 2015 Feb; 274(2):416-25. PMID: 25247408; PMCID: PMC4314291.
      52. Patel NS, Doycheva I, Peterson MR, Hooker J, Kisselva T, Schnabl B, Seki E, Sirlin C, Loomba R. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):561-568.e1. PMID: 25218667; PMCID: PMC4333065.
      53. Choi JY, Lee JM, Sirlin C. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014 Sep; 272(3):635-54. PMID: 25153274; PMCID: PMC4263631.
      54. Bashir MR, Sirlin C, Reeder SB. On confirmation bias in imaging research. J Magn Reson Imaging. 2015 May; 41(5):1163-4. PMID: 25124454.
        View in: PubMed
      55. Santillan CS, Tang A, Cruite I, Shah A, Sirlin C. Understanding LI-RADS: a primer for practical use. Magn Reson Imaging Clin N Am. 2014 Aug; 22(3):337-52. PMID: 25086933.
        View in: PubMed
      56. Jha RC, Mitchell DG, Weinreb JC, Santillan CS, Yeh BM, Francois R, Sirlin C. LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas. AJR Am J Roentgenol. 2014 Jul; 203(1):W48-69. PMID: 24951229.
        View in: PubMed
      57. Bonekamp S, Tang A, Mashhood A, Wolfson T, Changchien C, Middleton MS, Clark L, Gamst A, Loomba R, Sirlin C. Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging. 2014 Jun; 39(6):1525-32. PMID: 24987758; PMCID: PMC4083476.
      58. Smorodinsky E, Ansdell DS, Foster ZW, Mazhar SM, Cruite I, Wolfson T, Sugay SB, Iussich G, Shiehmorteza M, Kono Y, Kuo A, Sirlin C. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents. J Magn Reson Imaging. 2015 May; 41(5):1259-67. PMID: 24811860.
        View in: PubMed
      59. Choi JY, Kim H, Sun M, Sirlin C. Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations. Yonsei Med J. 2014 May; 55(3):651-9. PMID: 24719131; PMCID: PMC3990078.
      60. Hernando D, Levin YS, Sirlin C, Reeder SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging. 2014 Nov; 40(5):1003-21. PMID: 24585403; PMCID: PMC4308740.
      61. Patel NS, Peterson MR, Lin GY, Feldstein A, Schnabl B, Bettencourt R, Seki E, Sirlin C, Loomba R. Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterol Res Pract. 2013; 2013:498296. PMID: 24348536; PMCID: PMC3855930.
      62. Sirlin C, Hussain HK, Jonas E, Kanematsu M, Min Lee J, Merkle EM, Peck-Radosavljevic M, Reeder SB, Ricke J, Sakamoto M. Consensus report from the 6th International forum for liver MRI using gadoxetic acid. J Magn Reson Imaging. 2014 Sep; 40(3):516-29. PMID: 24923695.
        View in: PubMed
      63. Negrete LM, Middleton MS, Clark L, Wolfson T, Gamst AC, Lam J, Changchien C, Deyoung-Dominguez IM, Hamilton G, Loomba R, Schwimmer J, Sirlin C. Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging. 2014 May; 39(5):1265-71. PMID: 24136736; PMCID: PMC3984359.
      64. Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, Loomba R. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013 Dec; 58(6):1930-40. PMID: 23696515; PMCID: PMC4819962.
      65. Awai HI, Newton KP, Sirlin C, Behling C, Schwimmer JB. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol. 2014 May; 12(5):765-73. PMID: 24090729; PMCID: PMC3969892.
      66. Levin YS, Yokoo T, Wolfson T, Gamst AC, Collins J, Achmad EA, Hamilton G, Middleton MS, Loomba R, Sirlin C. Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimation. J Magn Reson Imaging. 2014 Mar; 39(3):567-75. PMID: 23720420; PMCID: PMC3760998.
      67. Liau J, Shiehmorteza M, Girard OM, Sirlin C, Bydder M. Evaluation of MRI fat fraction in the liver and spine pre and post SPIO infusion. Magn Reson Imaging. 2013 Jul; 31(6):1012-6. PMID: 23602721; PMCID: PMC3676690.
      68. Johnson BL, Schroeder ME, Wolfson T, Gamst AC, Hamilton G, Shiehmorteza M, Loomba R, Schwimmer JB, Reeder S, Middleton MS, Sirlin C. Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging. 2014 Feb; 39(2):440-7. PMID: 23596052; PMCID: PMC3732566.
      69. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin C. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013 May; 267(2):422-31. PMID: 23382291; PMCID: PMC3632805.
      70. Murphy P, Wolfson T, Gamst A, Sirlin C, Bydder M. Error model for reduction of cardiac and respiratory motion effects in quantitative liver DW-MRI. Magn Reson Med. 2013 Nov; 70(5):1460-9. PMID: 23280855; PMCID: PMC4142067.
      71. Mashhood A, Railkar R, Yokoo T, Levin Y, Clark L, Fox-Bosetti S, Middleton MS, Riek J, Kauh E, Dardzinski BJ, Williams D, Sirlin C, Shire NJ. Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J Magn Reson Imaging. 2013 Jun; 37(6):1359-70. PMID: 23172799.
        View in: PubMed
      72. Sirlin C. Invited commentary. Radiographics. 2012 Nov-Dec; 32(7):1995-8; discussion 1998. PMID: 23304704.
        View in: PubMed
      73. Bahl G, Cruite I, Wolfson T, Gamst AC, Collins JM, Chavez AD, Barakat F, Hassanein T, Sirlin C. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images. J Magn Reson Imaging. 2012 Nov; 36(5):1154-61. PMID: 22851409; PMCID: PMC4803477.
      74. Reeder SB, Hu HH, Sirlin C. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging. 2012 Nov; 36(5):1011-4. PMID: 22777847; PMCID: PMC4779595.
      75. Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, Cohen BL, Brenner D, Sirlin C, Loomba R. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology. 2012 Sep; 56(3):922-32. PMID: 22431131; PMCID: PMC3400720.
      76. Hu HH, Börnert P, Hernando D, Kellman P, Ma J, Reeder S, Sirlin C. ISMRM workshop on fat-water separation: insights, applications and progress in MRI. Magn Reson Med. 2012 Aug; 68(2):378-88. PMID: 22693111; PMCID: PMC3575097.
      77. Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin C, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol. 2012 Jun; 47(6):368-75. PMID: 22543969.
        View in: PubMed
      78. Iwaisako K, Haimerl M, Paik YH, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM, Brenner DA, Schnabl B. Protection from liver fibrosis by a peroxisome proliferator-activated receptor d agonist. Proc Natl Acad Sci U S A. 2012 May 22; 109(21):E1369-76. PMID: 22538808; PMCID: PMC3361396.
      79. Lee JT, Liau J, Murphy P, Schroeder ME, Sirlin C, Bydder M. Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. Magn Reson Imaging. 2012 May; 30(4):572-8. PMID: 22285877; PMCID: PMC3327769.
      80. Hansen KH, Schroeder ME, Hamilton G, Sirlin C, Bydder M. Robustness of fat quantification using chemical shift imaging. Magn Reson Imaging. 2012 Feb; 30(2):151-7. PMID: 22055856; PMCID: PMC3254829.
      81. Reeder SB, Cruite I, Hamilton G, Sirlin C. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011 Oct; 34(4):spcone. PMID: 22025886.
        View in: PubMed
      82. Reeder SB, Cruite I, Hamilton G, Sirlin C. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011 Oct; 34(4):729-49. PMID: 21928307.
        View in: PubMed
      83. Liau J, Lee J, Schroeder ME, Sirlin C, Bydder M. Cardiac motion in diffusion-weighted MRI of the liver: artifact and a method of correction. J Magn Reson Imaging. 2012 Feb; 35(2):318-27. PMID: 21959926; PMCID: PMC3252483.
      84. Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, Bydder M, Middleton MS, Sirlin C. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging. 2011 Oct; 34(4):928-34. PMID: 21769986; PMCID: PMC4803481.
      85. Sirlin C. Science to practice: Can T1rho imaging be used to diagnose and assess the severity of hepatic fibrosis? Radiology. 2011 Jun; 259(3):619-20. PMID: 21602499.
        View in: PubMed
      86. Hines CD, Frydrychowicz A, Hamilton G, Tudorascu DL, Vigen KK, Yu H, McKenzie CA, Sirlin C, Brittain JH, Reeder SB. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging. 2011 Apr; 33(4):873-81. PMID: 21448952; PMCID: PMC3130738.
      87. Yu H, Shimakawa A, Hines CD, McKenzie CA, Hamilton G, Sirlin C, Brittain JH, Reeder SB. Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med. 2011 Jul; 66(1):199-206. PMID: 21695724; PMCID: PMC3130743.
      88. Barshop NJ, Capparelli EV, Sirlin C, Schwimmer JB, Lavine JE. Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2011 Feb; 52(2):198-202. PMID: 21240014; PMCID: PMC3059772.
      89. Meisamy S, Hines CD, Hamilton G, Sirlin C, McKenzie CA, Yu H, Brittain JH, Reeder SB. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011 Mar; 258(3):767-75. PMID: 21248233; PMCID: PMC3042638.
      90. Yokoo T, Shiehmorteza M, Hamilton G, Wolfson T, Schroeder ME, Middleton MS, Bydder M, Gamst AC, Kono Y, Kuo A, Patton HM, Horgan S, Lavine JE, Schwimmer JB, Sirlin C. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology. 2011 Mar; 258(3):749-59. PMID: 21212366; PMCID: PMC3042639.
      91. Bydder M, Yokoo T, Yu H, Carl M, Reeder SB, Sirlin C. Constraining the initial phase in water-fat separation. Magn Reson Imaging. 2011 Feb; 29(2):216-21. PMID: 21159457; PMCID: PMC3053064.
      92. Hamilton G, Yokoo T, Bydder M, Cruite I, Schroeder ME, Sirlin C, Middleton MS. In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed. 2011 Aug; 24(7):784-90. PMID: 21834002; PMCID: PMC3860876.
      93. Reeder SB, Sirlin C. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010 Aug; 18(3):337-57, ix. PMID: 21094444; PMCID: PMC3002753.
      94. Sirlin C, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am. 2010 Aug; 18(3):359-81, ix. PMID: 21094445; PMCID: PMC3430384.
      95. Ganesan K, Achmad E, Sirlin C, Bouvet M, Datnow B, Weidner N, Peterson MR. Amphicrine carcinoma of the liver. Ann Diagn Pathol. 2011 Oct; 15(5):355-7. PMID: 20952282.
        View in: PubMed
      96. Cruite I, Schroeder M, Merkle EM, Sirlin C. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol. 2010 Jul; 195(1):29-41. PMID: 20566795.
        View in: PubMed
      97. Mwangi I, Hanna RF, Kased N, Malek P, Shiehmorteza M, Wolfson T, Gamst A, Sirlin C. Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. AJR Am J Roentgenol. 2010 Jun; 194(6):1515-22. PMID: 20489091.
        View in: PubMed
      98. Yokoo T, Bae WC, Hamilton G, Karimi A, Borgstede JP, Bowen BC, Sirlin C, Chung CB, Crues JV, Bradley WG, Bydder GM. A quantitative approach to sequence and image weighting. J Comput Assist Tomogr. 2010 May-Jun; 34(3):317-31. PMID: 20498530.
        View in: PubMed
      99. Bydder M, Shiehmorteza M, Yokoo T, Sugay S, Middleton MS, Girard O, Schroeder ME, Wolfson T, Gamst A, Sirlin C. Assessment of liver fat quantification in the presence of iron. Magn Reson Imaging. 2010 Jul; 28(6):767-76. PMID: 20409663; PMCID: PMC2924146.
      100. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin C. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010 Apr; 138(4):1357-64, 1364.e1-2. PMID: 20064512; PMCID: PMC2846968.
      101. Lindbäck SM, Gabbert C, Johnson BL, Smorodinsky E, Sirlin C, Garcia N, Pardee PE, Kistler KD, Schwimmer JB. Pediatric nonalcoholic fatty liver disease: a comprehensive review. Adv Pediatr. 2010; 57(1):85-140. PMID: 21056736.
        View in: PubMed
      102. Mazhar SM, Shiehmorteza M, Kohl CA, Middleton MS, Sirlin C. Nephrogenic systemic fibrosis in liver disease: a systematic review. J Magn Reson Imaging. 2009 Dec; 30(6):1313-22. PMID: 19937937; PMCID: PMC2844250.
      103. Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G, Sirlin C. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009 Oct; 29(6):1615-35. PMID: 19959511.
        View in: PubMed
      104. Loomba R, Sirlin C, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009 Oct; 50(4):1282-93. PMID: 19637286; PMCID: PMC2757471.
      105. Shiehmorteza M, Sirlin C, Wolfson T, Gamst A, Soumekh AE, Heaton SP, Kohl CA, Pinto N, Bydder M. Effect of shot number on the calculated apparent diffusion coefficient in phantoms and in human liver in diffusion-weighted echo-planar imaging. J Magn Reson Imaging. 2009 Sep; 30(3):547-53. PMID: 19711409.
        View in: PubMed
      106. Sirlin C. Invited commentary. Radiographics. 2009 Sep-Oct; 29(5):1277-80. PMID: 19764109.
        View in: PubMed
      107. Hamilton G, Middleton MS, Bydder M, Yokoo T, Schwimmer JB, Kono Y, Patton HM, Lavine JE, Sirlin C. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging. 2009 Jul; 30(1):145-52. PMID: 19557733; PMCID: PMC2982807.
      108. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, Hassanein T, Patton HM, Lavine JE, Schwimmer JB, Sirlin C. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009 Apr; 251(1):67-76. PMID: 19221054; PMCID: PMC2663579.
      109. Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, Shiehmorteza M, Yokoo T, Chavez A, Middleton MS, Sirlin C. Heritability of nonalcoholic fatty liver disease. Gastroenterology. 2009 May; 136(5):1585-92. PMID: 19208353; PMCID: PMC3397140.
      110. Cassidy FH, Yokoo T, Aganovic L, Hanna RF, Bydder M, Middleton MS, Hamilton G, Chavez AD, Schwimmer JB, Sirlin C. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics. 2009 Jan-Feb; 29(1):231-60. PMID: 19168847.
        View in: PubMed
      111. Mazhar SM, Shiehmorteza M, Sirlin C. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):135-40. PMID: 19118644.
        View in: PubMed
      112. Yokoo T, Collins JM, Hanna RF, Bydder M, Middleton MS, Sirlin C. Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging. J Magn Reson Imaging. 2008 Jul; 28(1):246-51. PMID: 18581393.
        View in: PubMed
      113. Bydder M, Hamilton G, Yokoo T, Sirlin C. Optimal phased-array combination for spectroscopy. Magn Reson Imaging. 2008 Jul; 26(6):847-50. PMID: 18486392; PMCID: PMC2868913.
      114. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin C. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008 May-Jun; 28(3):747-69. PMID: 18480482.
        View in: PubMed
      115. Yeh BM, Joe BN, Sirlin C, Webb EM, Westphalen AC, Qayyum A, Coakley FV. Vascular contact with soft tissue: a sign of mesenteric masses at computed tomography. J Comput Assist Tomogr. 2008 Mar-Apr; 32(2):185-90. PMID: 18379299; PMCID: PMC2724062.
      116. Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin C. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging. 2008 Apr; 26(3):347-59. PMID: 18093781; PMCID: PMC2386876.
      117. Hanna RF, Kased N, Kwan SW, Gamst AC, Santosa AC, Hassanein T, Sirlin C. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol. 2008 Jan; 190(1):47-57. PMID: 18094293.
        View in: PubMed
      118. Leite NP, Kased N, Hanna RF, Brown MA, Pereira JM, Cunha R, Sirlin C. Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics. 2007 Nov-Dec; 27(6):1613-34. PMID: 18025507.
        View in: PubMed
      119. Hughes-Cassidy F, Chavez AD, Schlang A, Hassanein T, Gamst A, Wolfson T, Sirlin C. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging. 2007 Sep; 26(3):728-37. PMID: 17685418.
        View in: PubMed
      120. Kuo MD, Gollub J, Sirlin C, Ooi C, Chen X. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol. 2007 Jul; 18(7):821-31. PMID: 17609439.
        View in: PubMed
      121. Hamer OW, Schlottmann K, Sirlin C, Feuerbach S. Technology insight: advances in liver imaging. Nat Clin Pract Gastroenterol Hepatol. 2007 Apr; 4(4):215-28. PMID: 17404589.
        View in: PubMed
      122. Tamburrini S, Brunetti A, Brown M, Sirlin C, Casola G. Acute appendicitis: diagnostic value of nonenhanced CT with selective use of contrast in routine clinical settings. Eur Radiol. 2007 Aug; 17(8):2055-61. PMID: 17180324.
        View in: PubMed
      123. Hall FM, Casola G, Sirlin C, Furtado CD, Aguirre DA, Brown MA. Callback and follow-up guidelines for whole-body CT screening. Radiology. 2006 Nov; 241(2):627-8; author reply 628-9. PMID: 17057082.
        View in: PubMed
      124. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin C. MR contrast agents for liver imaging: what, when, how. Radiographics. 2006 Nov-Dec; 26(6):1621-36. PMID: 17102040.
        View in: PubMed
      125. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin C. Fatty liver: imaging patterns and pitfalls. Radiographics. 2006 Nov-Dec; 26(6):1637-53. PMID: 17102041.
        View in: PubMed
      126. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006 Oct; 43(4):413-27. PMID: 17033514.
        View in: PubMed
      127. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin C. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology. 2006 May; 239(2):425-37. PMID: 16641352.
        View in: PubMed
      128. Brown MA, Mattrey RF, Stamato S, Sirlin C. MRI of the female pelvis using vaginal gel. AJR Am J Roentgenol. 2005 Nov; 185(5):1221-7. PMID: 16247138.
        View in: PubMed
      129. Aguirre DA, Santosa AC, Casola G, Sirlin C. Abdominal wall hernias: imaging features, complications, and diagnostic pitfalls at multi-detector row CT. Radiographics. 2005 Nov-Dec; 25(6):1501-20. PMID: 16284131.
        View in: PubMed
      130. Yoo RY, Sirlin C, Gottschalk M, Chang RJ. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. Fertil Steril. 2005 Oct; 84(4):985-95. PMID: 16213854.
        View in: PubMed
      131. Hamer OW, Sirlin C, Strotzer M, Borisch I, Zorger N, Feuerbach S, Völk M. Chest radiography with a flat-panel detector: image quality with dose reduction after copper filtration. Radiology. 2005 Nov; 237(2):691-700. PMID: 16192324.
        View in: PubMed
      132. Furtado CD, Aguirre DA, Sirlin C, Dang D, Stamato SK, Lee P, Sani F, Brown MA, Levin DL, Casola G. Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology. 2005 Nov; 237(2):385-94. PMID: 16170016.
        View in: PubMed
      133. Hamer OW, Aguirre DA, Casola G, Sirlin C. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology. 2005 Oct; 237(1):159-69. PMID: 16100085.
        View in: PubMed
      134. Tamburrini S, Brunetti A, Brown M, Sirlin C, Casola G. CT appearance of the normal appendix in adults. Eur Radiol. 2005 Oct; 15(10):2096-103. PMID: 15912331.
        View in: PubMed
      135. Brown MA, Sirlin C. Female pelvis. Magn Reson Imaging Clin N Am. 2005 May; 13(2):381-95. PMID: 15935318.
        View in: PubMed
      136. Farahmand N, Sirlin C, Brown MA, Shragg GP, Fortlage D, Hoyt DB, Casola G. Hypotensive patients with blunt abdominal trauma: performance of screening US. Radiology. 2005 May; 235(2):436-43. PMID: 15798158.
        View in: PubMed
      137. Laufik M, Buono D, Casola G, Sirlin C. Delayed traumatic bladder rupture. AJR Am J Roentgenol. 2005 Mar; 184(3 Suppl):S99-S101. PMID: 15728038.
        View in: PubMed
      138. Brown MA, Sirlin C, Farahmand N, Hoyt DB, Casola G. Screening sonography in pregnant patients with blunt abdominal trauma. J Ultrasound Med. 2005 Feb; 24(2):175-81; quiz 183-184. PMID: 15661948.
        View in: PubMed
      139. Pereira JM, Sirlin C, Pinto PS, Casola G. CT and MR imaging of extrahepatic fatty masses of the abdomen and pelvis: techniques, diagnosis, differential diagnosis, and pitfalls. Radiographics. 2005 Jan-Feb; 25(1):69-85. PMID: 15653588.
        View in: PubMed
      140. Sirlin C, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol. 2004 Dec; 11(12):1361-9. PMID: 15596374.
        View in: PubMed
      141. Aguirre DA, Casola G, Sirlin C. Abdominal wall hernias: MDCT findings. AJR Am J Roentgenol. 2004 Sep; 183(3):681-90. PMID: 15333356.
        View in: PubMed
      142. Pereira JM, Sirlin C, Pinto PS, Jeffrey RB, Stella DL, Casola G. Disproportionate fat stranding: a helpful CT sign in patients with acute abdominal pain. Radiographics. 2004 May-Jun; 24(3):703-15. PMID: 15143223.
        View in: PubMed
      143. Pinto PS, Sirlin C, Andrade-Barreto OA, Brown MA, Mindelzun RE, Mattrey RF. Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space. Radiographics. 2004 May-Jun; 24(3):809-17. PMID: 15143230.
        View in: PubMed
      144. Sirlin C, Brown MA, Andrade-Barreto OA, Deutsch R, Fortlage DA, Hoyt DB, Casola G. Blunt abdominal trauma: clinical value of negative screening US scans. Radiology. 2004 Mar; 230(3):661-8. PMID: 14990832.
        View in: PubMed
      145. Kono Y, Pinnell SP, Sirlin C, Sparks SR, Georgy B, Wong W, Mattrey RF. Carotid arteries: contrast-enhanced US angiography--preliminary clinical experience. Radiology. 2004 Feb; 230(2):561-8. PMID: 14699188.
        View in: PubMed
      146. Sirlin C, Brown MA, Deutsch R, Andrade-Barreto OA, Fortlage DA, Hoyt DB, Casola G. Screening US for blunt abdominal trauma: objective predictors of false-negative findings and missed injuries. Radiology. 2003 Dec; 229(3):766-74. PMID: 14657314.
        View in: PubMed
      147. Brown MA, Sirlin C, Hoyt DB, Casola G. Screening ultrasound in blunt abdominal trauma. J Intensive Care Med. 2003 Sep-Oct; 18(5):253-60. PMID: 15035759.
        View in: PubMed